Abiopharma

AAR and Woodward sign multi-year commercial distribution agreement

MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29

LiveOne (Nasdaq: LVO) Eliminates $15M+ Short-Term Liabilities, Delivering $13M+ in Cash Savings; Expands Stock Conversion Program to $15M+ at $7.50 per Share, with $8M Completed

Humacyte Appoints Jim Mercadante as Chief Commercial Officer

PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

Las Vegas Metropolitan Police Signs Five-Year WrapReality™ Contract Renewal with WRAP® to Advance Immersive Training and Non-Lethal Response™ Preparedness

Twin Disc Announces Details of Fiscal 2026 Third Quarter Earnings Release, Webcast, and Conference Call

PMV Pharmaceuticals Announces Board Chair Transition

The Beauty Health Company Announces Corporate Rebrand to SkinHealth Systems, Reflecting Evolution into a Clinically Driven, Science-Backed Medical Aesthetics Platform

Preferred Bank Reports First Quarter Results

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

IP Strategy Highlights the Story Global Wallet: Advancing Access to Programmable IP Infrastructure

Immutep Announces Abstract Accepted for Presentation at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting

Madrigal Pharmaceuticals to Release First-Quarter 2026 Financial Results and Host Webcast on May 6, 2026

red violet to Announce First Quarter 2026 Financial Results on May 6, 2026